| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7802204 | European Journal of Medicinal Chemistry | 2013 | 8 Pages |
Abstract
The two main metabolites (M4 and M5) of the clinical candidate RVX-208 were produced via biosynthesis, identified using LC-MS/MS and NMR, and the structures were confirmed via chemical synthesis.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yuri L. Khmelnitsky, Vadim V. Mozhaev, Ian C. Cotterill, Peter C. Michels, Sihem Boudjabi, Vladimir Khlebnikov, M. Madhava Reddy, Gregory S. Wagner, Henrik C. Hansen,